Showing results (291-300 of 2,330) with videos related to
Sort By:
Pageof 233
Clinical Drug Investigation|January 16, 2007
Medical costs of chronic musculoskeletal pain in ItalyLivio Garattini, Daniela Koleva, Nicola Motterlini, et al.Clinical Drug Investigation|February 20, 2007
Perindopril versus angiotensin II receptor blockade in hypertension and coronary artery disease: implications of clinical trialsAdrian J B BradyClinical Drug Investigation|February 20, 2007
Diclofenac potassium 12.5mg tablets for mild to moderate pain and fever: a review of its pharmacology, clinical efficacy and safetyNicholas MooreClinical Drug Investigation|February 20, 2007
Economic evaluation of voriconazole versus caspofungin for the treatment of invasive aspergillosis in SpainAlfonso Domínguez-Gil, Isabel Martín, Mercedes García Vargas, et al.Clinical Drug Investigation|February 6, 2007
Functional half-life is a meaningful descriptor of steady-state pharmacokinetics of an extended-release formulation of a rapidly cleared drug : as shown by once-daily divalproex-ERSandeep Dutta, Ronald C ReedClinical Drug Investigation|February 6, 2007
Neoadjuvant treatment with paclitaxel and epirubicin in invasive breast cancer: a phase II studyDavid Sarid, Ilan G Ron, Fani Sperber, et al.Clinical Drug Investigation|February 6, 2007
Real-life treatment of acute exacerbations of chronic bronchitis with moxifloxacin or macrolides: a comparative post-marketing surveillance study in general practiceT Schaberg, M Möller, T File, et al.Clinical Drug Investigation|November 11, 2008
Metabolism, distribution and elimination of lisdexamfetamine dimesylate: open-label, single-centre, phase I study in healthy adult volunteersSuma M Krishnan, Michael Pennick, Jeffrey G StarkClinical Drug Investigation|April 16, 2009
HairMax LaserComb laser phototherapy device in the treatment of male androgenetic alopecia: A randomized, double-blind, sham device-controlled, multicentre trialMatt Leavitt, Glenn Charles, Eugene Heyman, et al.Clinical Drug Investigation|April 16, 2009
Pharmacokinetics of two 6-day frovatriptan dosing regimens used for the short-term prevention of menstrual migraine: A phase I, randomized, double-blind, placebo-controlled, two-period crossover, single-centre study in healthy female volunteersAndrew Wade, Stephen Pawsey, Holly Whale, et al.Pageof 233